Taiwan’s strong medical background could transform it into an Asian hub for precision medicine
By: Judy Lin, Taiwan News, Staff Reporter
TAIPEI (Taiwan News)—Taiwan’s biotech and pharmaceutical industry was one of the
first to be named in the original Tsai Administration’s 5+2 economic policy to transform the nation’s economic structure, and is viewed as the upcoming medical treatment trend that Taiwan cannot miss out on, said Johnsee Lee (李鐘熙), the Honorary Chairman of Taiwan Bio Industry Organization (Taiwan BIO) during the Precision Medicine Industry Forum 2017 in Taipei, Wednesday.
“Even though we’ve seen some of Taiwan’s industry wane or are face intensified competition, Taiwan’s local medicine capacity remains strong,” said PricewaterhouseCoopers Taiwan Chairman Chang Ming-Huei (張明輝).